BETHESDA, Md., Jan. 10, 2025 /PRNewswire/ — SAR, a data analytics company specialized in the securities litigation risk of U.S. public companies, today published the Securities Class Action Rule 10b-5 Exposure Report for 4Q 2024. According to the report, securities litigation exposure of…
Month: January 2025
BETHESDA, Md., Jan. 10, 2025 /PRNewswire/ — SAR, a data analytics company specialized in the securities litigation risk of U.S. public companies, today published the Securities Class Action Rule 10b-5 Exposure Report for 4Q 2024. According to the report, securities litigation exposure of…
The Archaeological Conservancy and Gales Ferry Intermodal, LLC (GFI) are excited to announce they have entered into a donation agreement for the Fort Decatur archaeological site. Located in Ledyard, Connecticut, Fort Decatur is one of the state’s most significant War of 1812 sites, and is…
The Archaeological Conservancy and Gales Ferry Intermodal, LLC (GFI) are excited to announce they have entered into a donation agreement for the Fort Decatur archaeological site. Located in Ledyard, Connecticut, Fort Decatur is one of the state’s most significant War of 1812 sites, and is…
Company has been a member of the Los Angeles business community for 25 years and is committed to supporting its affected employees and the wider relief efforts NEW YORK and LOS ANGELES, Jan. 10, 2025 /PRNewswire/ — FanDuel, its parent company Flutter Entertainment (NYSE: FLUT) and fellow…
LOS ANGELES, Jan. 10, 2025 /PRNewswire/ — Today, Liberty Hill Foundation and its grantmaking partners announced the launch of award applications for the Environmental Protection Agency (EPA) Thriving Communities Grantmaking Program, which will invest $48 million in grants into…
Twenty-seven patients with Chronic Hepatitis B Virus infection (CHB) have now been dosed with VRON-0200 as a single (Prime), or Prime and Boost, intramuscular (i.m.) injection PHILADELPHIA, Jan. 10, 2025 /PRNewswire/ — Virion Therapeutics, LLC, a clinical-stage biotechnology company,…
Partnership will leverage Iktos’s AI-enabled drug discovery platform and Cube Biotech’s advanced protein technologies to develop novel agonists of the Amylin Receptor PARIS and MONHEIM, Germany, Jan. 10, 2025 /PRNewswire/ — Iktos, a leader in Artificial Intelligence (AI) and Robotics for…
Emerging Technologies Revolutionize Chronic Disease Management: Insights into Bio-Wearables, Digital Therapeutics, and AI-Driven Solutions BOSTON, Jan. 10, 2025 /PRNewswire/ — According to the latest study from BCC Research, “Chronic Disease Management: Therapeutics, Device Technologies,…
STOCKHOLM, Jan. 10, 2025 /PRNewswire/ — Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO:SOBI) announces today that revenue for the full year 2024 was higher than previous estimate. Full-year revenue was approximately SEK 26,000 M, representing approximately 19% growth at constant…